Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
In 1986, Kärre and colleagues reported that natural killer (NK) cells rejected an MHC class I-deficient tumor cell line (RMA-S) but they did not reject the same cell line if it expressed MHC class I (RMA). Based on this observation, they proposed the concept that NK cells provide immune surveillance for “missing self,” e.g., they eliminate cells that have lost class I MHC antigens. This seminal observation predicted the existence of inhibitory NK cell receptors for MHC class I. Here, we present evidence that NK cells are able to reject tumors expressing MHC class I if the tumor expresses a ligand for NKG2D. Mock-transfected RMA cells resulted in tumor formation. In contrast, when RMA cells were transfected with the retinoic acid early inducible gene-1 γ or δ (RAE-1), ligands for the activating receptor NKG2D, the tumors were rejected. The tumor rejection was mediated by NK cells, and not by CD1-restricted NK1.1 + T cells. No T cell-mediated immunological memory against the parental tumor was generated in the animals that had rejected the RAE-1 transfected tumors, which succumbed to rechallenge with the parental RMA tumor. Therefore, NK cells are able to reject a tumor expressing RAE-1 molecules, despite expression of self MHC class I on the tumor, demonstrating the potential for NK cells to participate in immunity against class I-bearing malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“NKG2D has been implicated in immune surveillance of tumors using transgenic models of spontaneous cancer as well as subcutaneous tumor transfer models (Cerwenka et al., 2001; Diefenbach et al., 2001; Guerra et al., 2008).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Cerwenka et al., 2001
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Self-citationBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Self-citationCosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,232
An Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039
Self-citationBroad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Groh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., & Spies, T. (2001) · Nature Immunology · doi:10.1038/85321 · Cited by 951
Research works printed but not linked: 2
- 10.1146/annurev.iy.10.040192.001201 · doi:10.1146/annurev.iy.10.040192.001201 · Paper page
- S Bahram Adv Immunol 76, 1–60 (2000).
Cited by
Items 201–300 of 691
Strategies of Natural Killer Cell Recognition and Signaling
Stewart, C. A., Vivier, É., & Colonna, M. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-27743-9_1 · Cited by 84
Innate Immune Recognition and Suppression of Tumors
Hayakawa, Y., & Smyth, M. J. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)95008-8 · Cited by 85
Stress Signals Activate Natural Killer Cells
Long, E. O., & Rajagopalan, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021747 · Cited by 83
Routes, J. M., Ryan, S., Morris, K. R., Takaki, R., Cerwenka, A., & Lanier, L. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050240 · Cited by 82
Self-citationFratricide of natural killer cells dressed with tumor-derived NKG2D ligand
Nakamura, K., NAKAYAMA, M., Kawano, M., Amagai, R., Ishii, T., Harigae, H., & Ogasawara, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300140110 · Cited by 82
A renaissance for the tumor immunosurveillance hypothesis
Lanier, L. L. (2001) · Nature Medicine · doi:10.1038/nm1101-1178 · Cited by 82
Self-citationMMP9 mediates MICA shedding in human osteosarcomas
Sun, D., Wang, X., Zhang, H., Deng, L., & Zhang, Y. (2011) · Cell Biology International · doi:10.1042/cbi20100431 · Cited by 81
Katano, I., Nishime, C., Ito, R., Kamisako, T., Mizusawa, T., Ka, Y., Ogura, T., Suemizu, H., Kawakami, Y., Ito, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17442-7 · Cited by 81
Cadoux, M., Caruso, S., Pham, S., Gougèlet, A., Pophillat, C., Riou, R., Loesch, R., Colnot, S., Nguyễn, C. T., Caldéraro, J., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.017 · Cited by 83
Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance
Unni, A. M., Bondar, T., & Medzhitov, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701675105 · Cited by 80
Molecular Bases for the Regulation of NKG2D Ligands in Cancer
Huergo-Zapico, L., Acebes‐Huerta, A., López‐Soto, A., Villa-Ãlvarez, M. N., González, A. P., & Gonzalez, S. R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00106 · Cited by 80
Conejo-Garcia, J. R., Benencia, F., Courreges, M. C., Gimotty, P. A., Khang, E., Buckanovich, R. J., Frauwirth, K. A., Zhang, L., Katsaros, D., Thompson, C. B., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2194 · Cited by 80
The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
Tan, G., Spillane, K. M., & Maher, J. F. (2023) · Biology · doi:10.3390/biology12081079 · Cited by 79
Min, D., Lu, X., Wang, X., Zhang, B., Meng, W., Yu, F., & Hu, H. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.337 · Cited by 79
Enhanced adaptive immune responses in lung adenocarcinoma through natural killer cell stimulation
Schmidt, L., Eskiocak, B., Kohn, R., Dang, C., Joshi, N. S., DuPage, M. J. P., Lee, D.-Y., & Jacks, T. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904253116 · Cited by 79
Tumor immunotherapy: New aspects of natural killer cells
Li, Y., & Sun, R. (2018) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2018.02.02 · Cited by 76
He, S., Yin, T., Li, D., Gao, X., Wan, Y., Ma, X., Ye, T., Guo, F., Sun, J., Lin, Z., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-186 · Cited by 75
Rodríguez‐Rodero, S., Gonzalez, S. R., Rodrigo, L., Fernández-Morera, J. L., Martínez-Borra, J., López‐Vázquez, A., & López‐Larrea, C. (2007) · European Journal of Immunology · doi:10.1002/eji.200737031 · Cited by 75
Muntasell, A., Magri, G., Pende, D., Angulo, A., & López‐Botet, M. (2010) · Blood · doi:10.1182/blood-2009-11-256479 · Cited by 75
Evasion of myofibroblasts from immune surveillance: A mechanism for tissue fibrosis
Wallach‐Dayan, S. B., Golan‐Gerstl, R., & Breuer, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705582104 · Cited by 75
Okita, R., Mougiakakos, D., Ando, T., Mao, Y., Sarhan, D., Wennerberg, E., Seliger, B., Lundqvist, A., Mimura, K., & Kiessling, R. W. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102237 · Cited by 73
Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review
Uppendahl, L. D., Dahl, C. M., Miller, J. S., Felices, M., & Geller, M. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01825 · Cited by 72
Dhanji, S., & Teh, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3442 · Cited by 71
Effect of splenectomy on antitumor immune system in mice.
Higashijima, J., Shimada, M., Chikakiyo, M., Miyatani, T., Yoshikawa, K., Nishioka, M., Iwata, T., & Kurita, N. (2009) · PubMed · Cited by 70
Sconocchia, G., Spagnoli, G. C., Principe, D. D., Ferrone, S., Anselmi, M., Wongsena, W., Cervelli, V., Schultz‐Thater, E., Wyler, S. F., Carafa, V., et al. (2009) · Neoplasia · doi:10.1593/neo.09296 · Cited by 70
Endt, J., McCann, F. E., Almeida, C. R., Urlaub, D., Leung, R., Pende, D., Davis, D. M., & Watzl, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5606 · Cited by 69
The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma
Sheppard, S., Guedes, J., Mróz, A., Zavitsanou, A., Kudo, H., ROTHERY, S. M., Angelopoulos, P., Goldin, R. D., & Guerra, N. (2017) · Nature Communications · doi:10.1038/ncomms13930 · Cited by 69
Kelly, J. M., Takeda, K., Darcy, P. K., Yagita∥, H., & Smyth, M. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4472 · Cited by 69
Coordination of activating and inhibitory signals in natural killer cells
Chiesa, S., Tomasello, E., Vivier, É., & Vely, F. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.030 · Cited by 69
Hesslein, D. G. T., Takaki, R., Hermiston, M. L., Weiss, A., & Lanier, L. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601851103 · Cited by 68
Self-citationSong, H., Hur, D. Y., Kim, K.-E., Park, H., Kim, T. S., Kim, C.-W., Bang, S., & Cho, D.-H. (2006) · Cellular Immunology · doi:10.1016/j.cellimm.2006.09.002 · Cited by 67
Böll, B., Eltaib, F. I., Reiners, K. S., von Tresckow, B., Tawadros, S., Simhadri, V. R., Burrows, F. J., Lundgren, K., Hansen, H. P., Engert, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0213 · Cited by 67
Wennerberg, E., Pfefferle, A., Ekblad, L., Yoshimoto, Y., Kremer, V., Kaminskyy, V. O., Juhlin, C. C., Höög, A., Bodin, I., Svjatoha, V., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0291 · Cited by 67
Raulet, D. H., Marcus, A., & Coscoy, L. (2017) · Immunological Reviews · doi:10.1111/imr.12600 · Cited by 65
Vangangelt, K. M. H., van Pelt, G. W., Engels, C. C., Putter, H., Liefers, G., Smit, V. T. H. B. M., Tollenaar, R. A. �. �., Kuppen, P. J. K., & Mesker, W. E. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4617-6 · Cited by 67
Innate and Innate-Like Cells: The Future of Chimeric Antigen Receptor (CAR) Cell Therapy
Cortés‐Selva, D., Dasgupta, B., Singh, S., & Grewal, I. S. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.11.004 · Cited by 66
Immune Surveillance of Unhealthy Cells by Natural Killer Cells
Iannello, A., & Raulet, D. H. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020255 · Cited by 54
Strong, R. K. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00032-9 · Cited by 66
Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy
Tarazona, R., Durán, E., & Solana, R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00649 · Cited by 66
Stress, NK Receptors, and Immune Surveillance
Pardoll, D. M. (2001) · Science · doi:10.1126/science.1066284 · Cited by 65
Regulation of NKG2D Expression and Signaling by Endocytosis
Molfetta, R., Quatrini, L., Zitti, B., Capuano, C., Galandrini, R., Santoni, A., & Paolini, R. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.08.015 · Cited by 64
The Paradoxical Role of NKG2D in Cancer Immunity
Sheppard, S., Ferry, A., Guedes, J., & Guerra, N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01808 · Cited by 64
Karimi, K., Boudreau, J. E., Fraser, K., Liu, H., Delanghe, J., Gauldie, J., Xing, Z., Bramson, J. L., & Wan, Y. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300347 · Cited by 64
Rothe, A., Jachimowicz, R. D., Borchmann, S., Madlener, M., Keßler, J., Reiners, K. S., Sauer, M., Hansen, H. P., Ullrich, R. T., Chatterjee, S., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28609 · Cited by 63
Capitalizing on the Immunogenicity of Dying Tumor Cells
Fonseca, C., & Dranoff, G. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2245 · Cited by 63
Nausch, N., Florin, L., Hartenstein, B., Angel, P. E., Schorpp‐Kistner, M., & Cerwenka, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.7 · Cited by 62
Self-citationConejo-Garcia, J. R., Benencia, F., Courreges, M. C., Khang, E., Zhang, L., Mohamed-Hadley, A. A., Vinocur, J. M., Buckanovich, R. J., Thompson, C. B., Levine, B. L., et al. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.4.479 · Cited by 62
NKG2D receptor–mediated NK cell function is regulated by inhibitory Ly49 receptors
Regunathan, J., Chen, Y., Wang, D., & Malarkannan, S. (2004) · Blood · doi:10.1182/blood-2004-03-1075 · Cited by 62
Tuning cancer fate: the unremitting role of host immunity
Calì, B., Molon, B., & Viola, A. (2017) · Open Biology · doi:10.1098/rsob.170006 · Cited by 62
Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D
Sayitoğlu, E. C., Georgoudaki, A., Chrobok, M., Özkazanç, D., Josey, B. J., Arif, M., Kusser, K. L., Hartman, M., Chinn, T. M., Potens, R., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00040 · Cited by 62
NK Cell Receptors as Tools in Cancer Immunotherapy
Sentman, C. L., Barber, M. A., Barber, A., & Zhang, T. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)95007-6 · Cited by 61
Gong, W., Xiao, W., Hu, M., Weng, X., Li, Q., Pan, X., & Ming-chun, J. (2010) · Tissue Antigens · doi:10.1111/j.1399-0039.2010.01535.x · Cited by 61
Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell
Bae, D. S., Hwang, Y. K., & Lee, J. K. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.04.011 · Cited by 59
Wortham, B. W., Eppert, B. L., Motz, G. T., Flury, J. L., Orozco‐Levi, M., Hoebe, K. H. N., Panos, R. J., Maxfield, M. D., Glasser, S. W., Senft, A. P., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102643 · Cited by 59
Cellular Expression, Trafficking, and Function of Two Isoforms of Human ULBP5/RAET1G
Eagle, R. A., Flack, G., Warford, A., Martínez-Borra, J., Jafferji, I., Traherne, J. A., Ohashi, M., Boyle, L. H., Barrow, A. D., Caillat‐Zucman, S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004503 · Cited by 59
Tissue-Specific Homing and Expansion of Donor NK Cells in Allogeneic Bone Marrow Transplantation
Olson, J. A., Zeiser, R., Beilhack, A., Goldman, J. J., & Negrin, R. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804268 · Cited by 58
TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors
Maccalli, C., Scaramuzza, S., & Parmiani, G. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0635-x · Cited by 58
Wu, J. D., Atteridge, C. L., Wang, X., Seya, T., & Plymate, S. R. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1305 · Cited by 58
Loss of JAK1 Drives Innate Immune Deficiency
Witalisz‐Siepracka, A., Klein, K., Prinz, D., Leidenfrost, N., Schabbauer, G., Dohnal, A. M., & Sexl, V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03108 · Cited by 58
Perspectives on cancer immuno‐epidemiology
Nakachi, K., Hayashi, T., Imai, K., & Kusunoki, Y. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03178.x · Cited by 58
Frenzel, L. P., Abdullah, Z., Kriegeskorte, A. K., Dieterich, R., Lange, N., Busch, D. H., Krönke, M., Utermöhlen, O., Hescheler, J., & Šarić, T. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0528 · Cited by 57
Westwood, J. A., Kelly, J. M., Tanner, J. E., Kershaw, M. H., Smyth, M. J., & Hayakawa, Y. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.757 · Cited by 56
Natural killer cell‐mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions
Backström, E., Chambers, B. J., Ho, E. L., Naidenko, O. V., Mariotti, R., Fremont, D. H., Yokoyama, W. M., Kristensson, K., & Ljunggren, H. (2003) · European Journal of Immunology · doi:10.1002/immu.200390012 · Cited by 55
Kellner, C., Maurer, T., Hallack, D., Repp, R., van de Winkel, J. G. J., Parren, P. W. H. I., Valerius, T., Humpe, A., Gramatzki, M., & Peipp, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201321 · Cited by 55
Huergo-Zapico, L., González, A. P., Contesti, J., González, E., López‐Soto, A., Fernández-Guizán, A., Acebes‐Huerta, A., Toyos, J. R. D. L., López‐Larrea, C., Groh, V., et al. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1195-z · Cited by 55
Geldhof, A. B., Ginderachter, J. A. V., Liu, Y., Noël, W., Raes, G., & BAETSELIER, P. D. (2002) · Blood · doi:10.1182/blood-2001-11-0106 · Cited by 55
DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor
Zhou, H., Luo, Y., Lo, J., Kaplan, C. D., Mizutani, M., Mizutani, N., Lee, J.-D., Primus, F. J., Becker, J. C., Xiang, R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502208102 · Cited by 55
Benitez, A. C., Dai, Z., Mann, H. H., Reeves, R. S., Margineantu, D. H., Gooley, T. A., Groh, V., & Spies, T. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018603108 · Cited by 54
Rubio, M., Saito, T. I., Kattleman, K., Zhao, G., Buchli, J., & Sykes, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.665 · Cited by 54
Barrier, B. F., Kendall, B. S., Ryan, C. E., & Sharpe-Timms, K. L. (2006) · Human Reproduction · doi:10.1093/humrep/dei408 · Cited by 49
Dupont, B., & Hsu, K. C. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.07.013 · Cited by 54
Tumor cell recognition by the NK cell activating receptor NKG2D
Bryceson, Y. T., & Ljunggren, H. (2008) · European Journal of Immunology · doi:10.1002/eji.200838833 · Cited by 53
Chen, Y., Chen, B., Yang, T., Xiao, W., Qian, L., Ding, Y., Ming-chun, J., Ge, X., & Gong, W. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.81 · Cited by 52
Tamaki, S., Sanefuzi, N., Kawakami, M., Aoki, K., Imai, Y., Yamanaka, Y., Yamamoto, K., Ishitani, A., Hatake, K., & Kirita, T. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.01.010 · Cited by 52
Fujii, S., Goto, A., & Shimizu, K. (2009) · Blood · doi:10.1182/blood-2008-08-176446 · Cited by 52
Activation of Natural Killer Cells: Underlying Molecular Mechanisms Revealed
Backström, E., Kristensson, K., & Ljunggren, H. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01475.x · Cited by 52
Tokuyama, M., Lorin, C., Delebecque, F., Jung, H., Raulet, D. H., & Coscoy, L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002265 · Cited by 51
Deguine, J., Bréart, B., Lemaître, F., & Bousso, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202065 · Cited by 51
Activating Signals Dominate Inhibitory Signals in CD137L/IL-15 Activated Natural Killer Cells
Zhang, H., Cui, Y., Voong, N., Sabatino, M., Stroncek, D. F., Morisot, S., Civin, C. I., Wayne, A. S., Levine, B. L., & Mackall, C. L. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31820d2a21 · Cited by 51
NKG2D: A versatile player in the immune system
Jelenčić, V., Lenartić, M., Wensveen, F. M., & Polić, B. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.04.006 · Cited by 51
Bouaziz, J., Ortonne, N., Giustiniani, J., Schiavon, V., Huet, D., Bagot, M., & Bensussan, A. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23914.x · Cited by 51
Busche, A., Goldmann, T., Naumann, U., Steinle, A., & Brandau, S. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.135 · Cited by 51
Toll-like receptor 3 regulates NK cell responses to cytokines and controls experimental metastasis
Guillerey, C., Chow, M. T., Miles, K. M., Olver, S. D., Sceneay, J., Takeda, K., Möller, A., & Smyth, M. J. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1027468 · Cited by 50
Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response
Jonjić, S. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00085 · Cited by 50
Murine cytomegalovirus regulation of NKG2D ligands
Roviš, T. L., Arapović, J., Traven, L., Krmpotić, A., & Jonjić, S. (2008) · Medical Microbiology and Immunology · doi:10.1007/s00430-008-0080-7 · Cited by 50
Wang, X., Lundgren, A. D., Singh, P., Goodlett, D. R., Plymate, S. R., & Wu, J. D. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.062 · Cited by 49
Du, Z., Huang, Z., Chen, X., Jiang, G., Peng, Y., Feng, W., & Huang, N. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00289-8 · Cited by 49
Osaki, T., Saito, H., Yoshikawa, T., Matsumoto, S., Tatebe, S., Tsujitani, S., & Ikeguchi, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1454 · Cited by 49
van Beek, J. J. P., Wimmers, F., Hato, S. V., de Vries, I. J. M., & Sköld, A. E. (2014) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2014012204 · Cited by 48
Märklin, M., Hagelstein, I., Koerner, S., Rothfelder, K., Pflügler, M., Schumacher, A., Große‐Hovest, L., Jung, G., & Salih, H. R. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0606-0 · Cited by 48
Burke, B., Eden, C., Pérez, C., Belshoff, A. C., Hart, S., Plaza-Rojas, L., Reyes, M. D., Prajapati, K., Voelkel‐Johnson, C., Henry, E., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00699 · Cited by 48
Re-educating natural killer cells
Sun, J. C.-Y. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101748 · Cited by 48
The NKG2D axis: an emerging target in cancer immunotherapy
Lazarova, M., & Steinle, A. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1580693 · Cited by 47
Natural killer cell–based immunotherapy for cancer
Ma, S., Yu, J., & Caligiuri, M. A. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf036 · Cited by 47
Depletion of ascorbic acid impairs NK cell activity against ovarian cancer in a mouse model
Kim, J.-E., Cho, H.-S., Yang, H.-S., Jung, D.-J., Hong, S.-W., Hung, C.-F., Lee, W. J., & Kim, D. (2012) · Immunobiology · doi:10.1016/j.imbio.2011.12.010 · Cited by 46
Kaur, K., Safaie, T., Ko, M.-W., Wang, Y., & Jewett, A. (2021) · Cancers · doi:10.3390/cancers13020239 · Cited by 46
Requirements for control of B‐cell lymphoma by NK cells
Brenner, C. D., King, S. B. S., Przewoznik, M., Wolters, I., Adam, C., Bornkamm, G. W., Busch, D. H., Röcken, M., & Mocikat, R. (2009) · European Journal of Immunology · doi:10.1002/eji.200939937 · Cited by 46
Xu, X., Rao, G., Gaffud, M. J., Ding, H. G., Maki, G., Klingemann, H.-G., Groh, V., Spies, T. A., Caillat‐Zucman, S., Gattuso, P., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0492 · Cited by 46
Ghosh, S., Paul, A., & Sen, E. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01254-12 · Cited by 46
Anatomy of a murder—signal transduction pathways leading to activation of natural killer cells
Zompì, S., & Colucci, F. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.10.006 · Cited by 44
Metadata
- Authors
- Cerwenka, A., Baron, J. L., & Lanier, L. L.
- Affiliations
- University of California, San Francisco (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-09-18
- Volume
- 98
- Issue
- 20
- Pages
- 11521-11526
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC58762
- OpenAlex
- W2056645320
- Cited by
- 606
- References
- 34
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 11 · 2023: 11 · 2022: 20 · 2021: 15 · 2020: 24 · 2019: 17 · 2018: 15 · 2017: 26 · 2016: 14 · 2015: 22 · 2014: 27 · 2013: 25 · 2012: 24
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- National Institutes of Health
- National Cancer Institute (CA89189, R01CA089189)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- Rae1, NKG2D, natural killer cells, MHC class I, tumor rejection, missing self, NK cell receptors, immune surveillance, NK1.1+ T cells, tumor rechallenge
- MeSH terms
- Animals, B-Lymphocytes, Female, Immunoglobulin Fc Fragments, Immunologic Memory, Killer Cells, Natural, Lymphocyte Depletion, Lymphoma, Major Histocompatibility Complex, Membrane Proteins, Mice, Inbred C57BL, Recombinant Fusion Proteins, Transfection, Tumor Cells, Cultured, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.